Attenuation of allergic contact dermatitis through the endocannabinoid system.

Cannabinoids have a potential therapeutic value in the treatment of psoriasis.
June 29, 2017
Topical CBD Products: An effective new possibility for treating skin conditions
June 29, 2017

Abstract: Allergic contact dermatitis affects about 5% of men and 11% of women in industrialized countries and is one of the leading causes for occupational diseases. In an animal model for cutaneous contact hypersensitivity, we show that mice lacking both known cannabinoid receptors display exacerbated allergic inflammation. In contrast, fatty acid amide hydrolase-deficient mice, which have increased levels of the endocannabinoid anandamide, displayed reduced allergic responses in the skin. Cannabinoid receptor antagonists exacerbated allergic inflammation, whereas receptor agonists attenuated inflammation. These results demonstrate a protective role of the endocannabinoid system in contact allergy in the skin and suggest a target for therapeutic intervention.

Link: US National Library of Medicine, National Institutes of Health